Donald A. Bergstrom, President of R&D at Relay Therapeutics ($RLAY), made eight open market sales of company shares over the past year, totaling $603,575. His latest sale occurred on January 28, 2026. These transactions rank 6,058th among 11,678 insiders in the database, trailing the average sale value of $8.6 million across 6.4 trades. Bergstrom recorded no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 28, 2026 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | S | Common Stock | 2686 | $8.45 | 420,047.0000 | 173,322,385 | 0.64% | 0.00% |
| Jan. 27, 2026 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | S | Common Stock | 18895 | $7.62 | 422,733.0000 | 173,322,385 | 4.28% | 0.01% |
| Jan. 13, 2026 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | A | Stock Option (Right to Buy) | 575000 | $0.00 | 575,000.0000 | 173,322,385 | 9999.99% | 0.33% |
| Oct. 28, 2025 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | S | Common Stock | 30897 | $7.29 | 521,823.0000 | 169,521,849 | 5.59% | 0.02% |
| July 28, 2025 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | S | Common Stock | 4069 | $3.74 | 579,421.0000 | 169,521,849 | 0.70% | 0.00% |
| July 29, 2025 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | S | Common Stock | 26701 | $3.68 | 552,720.0000 | 169,521,849 | 4.61% | 0.02% |
| April 30, 2025 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | S | Common Stock | 27472 | $3.00 | 583,490.0000 | 169,521,849 | 4.50% | 0.02% |
| April 28, 2025 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | S | Common Stock | 4090 | $3.17 | 610,962.0000 | 169,521,849 | 0.66% | 0.00% |
| March 27, 2025 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | S | Common Stock | 986 | $2.84 | 615,052.0000 | 169,521,849 | 0.16% | 0.00% |
| Jan. 30, 2025 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | S | Common Stock | 30823 | $4.42 | 616,038.0000 | 0 | 4.77% | 0.00% |
| Jan. 28, 2025 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | A | Common Stock | 176400 | $0.00 | 693,268.0000 | 0 | 34.13% | 0.00% |
| Jan. 28, 2025 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | S | Common Stock | 3220 | $4.63 | 516,868.0000 | 0 | 0.62% | 0.00% |
| Jan. 29, 2025 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | S | Common Stock | 46407 | $4.55 | 646,861.0000 | 0 | 6.69% | 0.00% |
| Jan. 10, 2025 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | A | Stock Option (Right to Buy) | 400000 | $0.00 | 400,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 27, 2024 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | S | Common Stock | 657 | $4.38 | 520,088.0000 | 0 | 0.13% | 0.00% |
| Oct. 28, 2024 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | S | Common Stock | 2688 | $6.06 | 520,745.0000 | 0 | 0.51% | 0.00% |
| Sept. 27, 2024 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | S | Common Stock | 648 | $7.51 | 523,433.0000 | 0 | 0.12% | 0.00% |
| July 29, 2024 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | S | Common Stock | 2698 | $8.85 | 524,081.0000 | 0 | 0.51% | 0.00% |
| June 27, 2024 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | S | Common Stock | 648 | $6.26 | 526,779.0000 | 0 | 0.12% | 0.00% |
| April 29, 2024 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | S | Common Stock | 2686 | $6.38 | 527,427.0000 | 0 | 0.51% | 0.00% |
| March 27, 2024 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | S | Common Stock | 765 | $7.70 | 530,113.0000 | 0 | 0.14% | 0.00% |
| Jan. 29, 2024 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | S | Common Stock | 3178 | $9.64 | 530,878.0000 | 0 | 0.60% | 0.00% |
| Jan. 16, 2024 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | A | Common Stock | 300000 | $0.00 | 534,056.0000 | 0 | 128.17% | 0.00% |
| Dec. 27, 2023 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | S | Common Stock | 977 | $11.51 | 234,056.0000 | 0 | 0.42% | 0.00% |
| Oct. 30, 2023 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | S | Common Stock | 3451 | $6.03 | 235,033.0000 | 0 | 1.45% | 0.00% |
| June 30, 2023 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | A | Common Stock | 1228 | $10.68 | 241,815.0000 | 0 | 0.51% | 0.00% |
| Sept. 27, 2023 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | S | Common Stock | 648 | $8.38 | 238,484.0000 | 0 | 0.27% | 0.00% |
| July 28, 2023 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | S | Common Stock | 2683 | $11.80 | 237,904.0000 | 0 | 1.12% | 0.00% |
| June 27, 2023 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | S | Common Stock | 647 | $12.12 | 240,587.0000 | 0 | 0.27% | 0.00% |
| April 28, 2023 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | S | Common Stock | 2850 | $11.16 | 241,234.0000 | 0 | 1.17% | 0.00% |
| April 28, 2023 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | S | Common Stock | 1383 | $11.16 | 242,701.0000 | 0 | 0.57% | 0.00% |
| March 27, 2023 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | S | Common Stock | 763 | $15.36 | 244,084.0000 | 0 | 0.31% | 0.00% |
| Jan. 30, 2023 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | S | Common Stock | 1429 | $21.56 | 244,847.0000 | 0 | 0.58% | 0.00% |
| Jan. 17, 2023 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | A | Stock Option (Right to Buy) | 160390 | $0.00 | 160,390.0000 | 0 | 9999.99% | 0.00% |
| Jan. 17, 2023 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | A | Stock Option (Right to Buy) | 160390 | $0.00 | 160,390.0000 | 0 | 9999.99% | 0.00% |
| Jan. 17, 2023 | Relay Therapeutics, Inc. | $RLAY | Bergstrom Donald A | President, R&D | A | Common Stock | 160390 | $0.00 | 246,276.0000 | 0 | 186.75% | 0.00% |